ポスター：Genedata Chromaticsによるクロマトグラフィーおよび電気泳動データワークフローの統合と効率化

December 9, 2025

クロマトグラフィーは、バイオ医薬品の分析評価と精製の基盤技術です。一方で、膨大なデータの取得・処理・解析・報告の負担に対するエラー防止や効率化が課題となっています。GenedataとGenmab社が共同開発したGenedata Chromatics^®は、多様な装置に対応した統合プラットフォームとしてワークフローを自動化し、主要なアッセイを効率的かつ一貫性ある形で解析可能にします。

Chromatography is the workhorse of biotherapeutic analytical assessment and purification. The rapid rise of biologics as therapeutics has exponentially increased the volume of data from chromatography workflows, making it burdensome to capture, process, analyze and report all these data. This leads to error-prone processes, poor scalability, incomparable results, wasted time and resources, and cost inefficiencies. To address these challenges, Genedata and Genmab—a leader in next-generation therapeutic antibodies--developed Genedata Chromatics^®, a central, integrated software platform for analyzing and managing chromatography data. Compatible with a wide range of instruments, this solution harmonizes data processing, eliminates manual steps, and provides well-annotated results for AI/ML initiatives. Here, we demonstrate how Chromatics automates the analysis of key chromatography and electrophoresis assays, including size-exclusion chromatography (SEC), Hydrophobic Interaction Chromatography (HIC), Capillary electrophoresis SDS (CE-SDS) and Capillary Isoelectric Focusing (cIEF), using end-to-end automated yet customizable workflows.